Circulating, cell-free methylated DNA indicates cellular sources of allograft injury after liver transplant.
Megan E McNamaraSidharth S JainKesha OzaVinona MuralidaranAmber J KilitiA Patrick McDeedDigvijay PatilYuki CuiMarcel O SchmidtVirginie OryAlexander H K KroemerAnton WellsteinPublished in: bioRxiv : the preprint server for biology (2024)
Post-transplant complications reduce allograft and recipient survival. Current approaches for detecting allograft injury non-invasively are limited and do not differentiate between cellular mechanisms. Here, we monitor cellular damages after liver transplants from cell-free DNA (cfDNA) fragments released from dying cells into the circulation. We analyzed 130 blood samples collected from 44 patients at different time points after transplant. Sequence-based methylation of cfDNA fragments were mapped to patterns established to identify cell types in different organs. For liver cell types DNA methylation patterns and multi-omic data integration show distinct enrichment in open chromatin and regulatory regions functionally important for the respective cell types. We find that multi-tissue cellular damages post-transplant recover in patients without allograft injury during the first post-operative week. However, sustained elevation of hepatocyte and biliary epithelial cfDNA beyond the first week indicates early-onset allograft injury. Further, cfDNA composition differentiates amongst causes of allograft injury indicating the potential for non-invasive monitoring and timely intervention.
Keyphrases
- early onset
- cell free
- dna methylation
- single cell
- kidney transplantation
- cell therapy
- gene expression
- genome wide
- randomized controlled trial
- circulating tumor
- transcription factor
- palliative care
- induced apoptosis
- late onset
- newly diagnosed
- end stage renal disease
- clinical trial
- dna damage
- stem cells
- mesenchymal stem cells
- electronic health record
- oxidative stress
- signaling pathway
- single molecule
- big data
- climate change
- cell death